Page last updated: 2024-08-25

panaxadiol and Colitis

panaxadiol has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jin, HL; Jin, X; Lee, JJ; Li, MY; Ma, J; Wang, JY; Xing, Y; Zhang, ZH; Zhong, Y; Zuo, HX	1

Other Studies

1 other study(ies) available for panaxadiol and Colitis

Article	Year
Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. Journal of ethnopharmacology, 2022, Jan-30, Volume: 283 Topics: Animals; Anti-Inflammatory Agents; Caspase 8; Colitis; Gene Knockdown Techniques; Ginsenosides; HEK293 Cells; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotective Agents; Panax; THP-1 Cells; Ubiquitin-Protein Ligases	2022

Article

Year

Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages.

Journal of ethnopharmacology, 2022, Jan-30, Volume: 283

Topics: Animals; Anti-Inflammatory Agents; Caspase 8; Colitis; Gene Knockdown Techniques; Ginsenosides; HEK293 Cells; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotective Agents; Panax; THP-1 Cells; Ubiquitin-Protein Ligases

2022